CJC-1295 in Pommerit-Jaudy — GHRH Analog Research Guide
CJC-1295 research guide for Pommerit-Jaudy. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Research-Grade CJC-1295 for Pommerit-Jaudy Investigators
For anyone in Pommerit-Jaudy searching for CJC-1295, the first thing to know is that this compound is available only through an online research supply market. The benefit of this online-only market is that serious vendors differentiate entirely through their analytical documentation, giving researchers access to better quality signals than any local market ever offers. What reliably differentiates top CJC-1295 vendors is full COA coverage: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for safety documentation. What follows is a sourcing and quality evaluation guide built specifically around CJC-1295, covering everything a Pommerit-Jaudy researcher needs before placing a first order.
What Studies Say About CJC-1295
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Pommerit-Jaudy researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
How to Evaluate CJC-1295 Vendors
Before looking at individual vendors, build a clear picture of what a proper COA looks like — so you can identify whether a supplier meets the standard. When reviewing a CJC-1295 COA, verify: the batch number traces to your order, HPLC purity is ≥98%, mass spec confirms the correct peptide, and endotoxin levels are at acceptable levels for the intended application. The combination of peer feedback and direct document verification is the gold standard for CJC-1295 sourcing — community feedback surfaces systemic problems invisible in one transaction, and vice versa. For Pommerit-Jaudy researchers making a first CJC-1295 purchase: apply these quality criteria before ordering, order conservatively at first, and check that batch numbers on your vial match the COA before use.
Order CJC-1295 — ships to Pommerit-Jaudy
COA-verified · International tracking · Research grade
All use of CJC-1295 in Pommerit-Jaudy or anywhere must be research use only — this compound is not approved for therapeutic human application, and all handling should follow research laboratory protocols. Temperature excursions — even short periods above −20°C — can partially degrade CJC-1295 without visible changes; always verify cold chain was maintained during shipping. Bacterial endotoxin contamination is the primary safety concern specific to research peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. Researchers combining CJC-1295 with other compounds should review the available literature for documented interactions before running stacked compound experiments.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
